The Hepatitis market is a subset of the larger Hepatology market, which focuses on the diagnosis, treatment, and prevention of liver diseases. Hepatitis is a viral infection that can cause inflammation of the liver, and can be caused by a variety of viruses, including hepatitis A, B, C, D, and E. Treatment for hepatitis can include antiviral medications, immunosuppressants, and interferon therapy. Vaccines are also available to prevent hepatitis A and B. The Hepatitis market is a growing field, with a focus on developing new treatments and therapies to improve patient outcomes. Companies in the market include Gilead Sciences, AbbVie, Merck, Bristol-Myers Squibb, and Novartis. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
